Global Immuno Oncology Assays Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 203265
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Immuno Oncology Assays market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immuno Oncology Assays size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Immuno Oncology Assays market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Immuno Oncology Assays market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Immunoassay

Flow Cytometry

PCR

Next Generation Sequencing

Market segment by Application, can be divided into

Research

Clinical Diagnostics

Market segment by players, this report covers

Thermo Fischer Scientific

Roche Diagnostics

Agilent Technologies

Illumina

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Immuno Oncology Assays

1.2 Classification of Immuno Oncology Assays

1.2.1 Overview: Global Immuno Oncology Assays Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Immuno Oncology Assays Revenue Market Share by Type in 2020

1.2.3 Immunoassay

1.2.4 Flow Cytometry

1.2.5 PCR

1.2.6 Next Generation Sequencing

1.3 Global Immuno Oncology Assays Market

1.3.1 Overview: Global Immuno Oncology Assays Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Research

1.3.3 Clinical Diagnostics

1.4 Global Immuno Oncology Assays Market Size & Forecast

1.5 Global Immuno Oncology Assays Market Size and Forecast by Region

1.5.1 Global Immuno Oncology Assays Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Immuno Oncology Assays Market Size by Region, (2016-2021)

1.5.3 North America Immuno Oncology Assays Market Size and Prospect (2016-2026)

1.5.4 Europe Immuno Oncology Assays Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Immuno Oncology Assays Market Size and Prospect (2016-2026)

1.5.6 South America Immuno Oncology Assays Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Immuno Oncology Assays Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Immuno Oncology Assays Market Drivers

1.6.2 Immuno Oncology Assays Market Restraints

1.6.3 Immuno Oncology Assays Trends Analysis

2 Company Profiles

2.1 Thermo Fischer Scientific

2.1.1 Thermo Fischer Scientific Details

2.1.2 Thermo Fischer Scientific Major Business

2.1.3 Thermo Fischer Scientific Immuno Oncology Assays Product and Solutions

2.1.4 Thermo Fischer Scientific Immuno Oncology Assays Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Thermo Fischer Scientific Recent Developments and Future Plans

2.2 Roche Diagnostics

2.2.1 Roche Diagnostics Details

2.2.2 Roche Diagnostics Major Business

2.2.3 Roche Diagnostics Immuno Oncology Assays Product and Solutions

2.2.4 Roche Diagnostics Immuno Oncology Assays Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Roche Diagnostics Recent Developments and Future Plans

2.3 Agilent Technologies

2.3.1 Agilent Technologies Details

2.3.2 Agilent Technologies Major Business

2.3.3 Agilent Technologies Immuno Oncology Assays Product and Solutions

2.3.4 Agilent Technologies Immuno Oncology Assays Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Agilent Technologies Recent Developments and Future Plans

2.4 Illumina

2.4.1 Illumina Details

2.4.2 Illumina Major Business

2.4.3 Illumina Immuno Oncology Assays Product and Solutions

2.4.4 Illumina Immuno Oncology Assays Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Illumina Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Immuno Oncology Assays Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Immuno Oncology Assays Players Market Share

3.2.2 Top 10 Immuno Oncology Assays Players Market Share

3.2.3 Market Competition Trend

3.3 Immuno Oncology Assays Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Immuno Oncology Assays Revenue and Market Share by Type (2016-2021)

4.2 Global Immuno Oncology Assays Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Immuno Oncology Assays Revenue Market Share by Application (2016-2021)

5.2 Immuno Oncology Assays Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Immuno Oncology Assays Revenue by Type (2016-2026)

6.2 North America Immuno Oncology Assays Revenue by Application (2016-2026)

6.3 North America Immuno Oncology Assays Market Size by Country

6.3.1 North America Immuno Oncology Assays Revenue by Country (2016-2026)

6.3.2 United States Immuno Oncology Assays Market Size and Forecast (2016-2026)

6.3.3 Canada Immuno Oncology Assays Market Size and Forecast (2016-2026)

6.3.4 Mexico Immuno Oncology Assays Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Immuno Oncology Assays Revenue by Type (2016-2026)

7.2 Europe Immuno Oncology Assays Revenue by Application (2016-2026)

7.3 Europe Immuno Oncology Assays Market Size by Country

7.3.1 Europe Immuno Oncology Assays Revenue by Country (2016-2026)

7.3.2 Germany Immuno Oncology Assays Market Size and Forecast (2016-2026)

7.3.3 France Immuno Oncology Assays Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Immuno Oncology Assays Market Size and Forecast (2016-2026)

7.3.5 Russia Immuno Oncology Assays Market Size and Forecast (2016-2026)

7.3.6 Italy Immuno Oncology Assays Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Immuno Oncology Assays Revenue by Type (2016-2026)

8.2 Asia-Pacific Immuno Oncology Assays Revenue by Application (2016-2026)

8.3 Asia-Pacific Immuno Oncology Assays Market Size by Region

8.3.1 Asia-Pacific Immuno Oncology Assays Revenue by Region (2016-2026)

8.3.2 China Immuno Oncology Assays Market Size and Forecast (2016-2026)

8.3.3 Japan Immuno Oncology Assays Market Size and Forecast (2016-2026)

8.3.4 South Korea Immuno Oncology Assays Market Size and Forecast (2016-2026)

8.3.5 India Immuno Oncology Assays Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Immuno Oncology Assays Market Size and Forecast (2016-2026)

8.3.7 Australia Immuno Oncology Assays Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Immuno Oncology Assays Revenue by Type (2016-2026)

9.2 South America Immuno Oncology Assays Revenue by Application (2016-2026)

9.3 South America Immuno Oncology Assays Market Size by Country

9.3.1 South America Immuno Oncology Assays Revenue by Country (2016-2026)

9.3.2 Brazil Immuno Oncology Assays Market Size and Forecast (2016-2026)

9.3.3 Argentina Immuno Oncology Assays Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Immuno Oncology Assays Revenue by Type (2016-2026)

10.2 Middle East & Africa Immuno Oncology Assays Revenue by Application (2016-2026)

10.3 Middle East & Africa Immuno Oncology Assays Market Size by Country

10.3.1 Middle East & Africa Immuno Oncology Assays Revenue by Country (2016-2026)

10.3.2 Turkey Immuno Oncology Assays Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Immuno Oncology Assays Market Size and Forecast (2016-2026)

10.3.4 UAE Immuno Oncology Assays Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Immuno Oncology Assays Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Immuno Oncology Assays Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Immuno Oncology Assays Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Immuno Oncology Assays Revenue (USD Million) by Region (2016-2021)

Table 5. Global Immuno Oncology Assays Revenue Market Share by Region (2021-2026)

Table 6. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fischer Scientific Major Business

Table 8. Thermo Fischer Scientific Immuno Oncology Assays Product and Solutions

Table 9. Thermo Fischer Scientific Immuno Oncology Assays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Roche Diagnostics Corporate Information, Head Office, and Major Competitors

Table 11. Roche Diagnostics Major Business

Table 12. Roche Diagnostics Immuno Oncology Assays Product and Solutions

Table 13. Roche Diagnostics Immuno Oncology Assays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 15. Agilent Technologies Major Business

Table 16. Agilent Technologies Immuno Oncology Assays Product and Solutions

Table 17. Agilent Technologies Immuno Oncology Assays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Illumina Corporate Information, Head Office, and Major Competitors

Table 19. Illumina Major Business

Table 20. Illumina Immuno Oncology Assays Product and Solutions

Table 21. Illumina Immuno Oncology Assays Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Global Immuno Oncology Assays Revenue (USD Million) by Players (2019-2021)

Table 23. Global Immuno Oncology Assays Revenue Share by Players (2019-2021)

Table 24. Breakdown of Immuno Oncology Assays by Company Type (Tier 1, Tier 2 and Tier 3)

Table 25. Immuno Oncology Assays Players Head Office, Products and Services Provided

Table 26. Immuno Oncology Assays Mergers & Acquisitions in the Past Five Years

Table 27. Immuno Oncology Assays New Entrants and Expansion Plans

Table 28. Global Immuno Oncology Assays Revenue (USD Million) by Type (2016-2021)

Table 29. Global Immuno Oncology Assays Revenue Share by Type (2016-2021)

Table 30. Global Immuno Oncology Assays Revenue Forecast by Type (2021-2026)

Table 31. Global Immuno Oncology Assays Revenue by Application (2016-2021)

Table 32. Global Immuno Oncology Assays Revenue Forecast by Application (2021-2026)

Table 33. North America Immuno Oncology Assays Revenue by Type (2016-2021) & (USD Million)

Table 34. North America Immuno Oncology Assays Revenue by Type (2021-2026) & (USD Million)

Table 35. North America Immuno Oncology Assays Revenue by Application (2016-2021) & (USD Million)

Table 36. North America Immuno Oncology Assays Revenue by Application (2021-2026) & (USD Million)

Table 37. North America Immuno Oncology Assays Revenue by Country (2016-2021) & (USD Million)

Table 38. North America Immuno Oncology Assays Revenue by Country (2021-2026) & (USD Million)

Table 39. Europe Immuno Oncology Assays Revenue by Type (2016-2021) & (USD Million)

Table 40. Europe Immuno Oncology Assays Revenue by Type (2021-2026) & (USD Million)

Table 41. Europe Immuno Oncology Assays Revenue by Application (2016-2021) & (USD Million)

Table 42. Europe Immuno Oncology Assays Revenue by Application (2021-2026) & (USD Million)

Table 43. Europe Immuno Oncology Assays Revenue by Country (2016-2021) & (USD Million)

Table 44. Europe Immuno Oncology Assays Revenue by Country (2021-2026) & (USD Million)

Table 45. Asia-Pacific Immuno Oncology Assays Revenue by Type (2016-2021) & (USD Million)

Table 46. Asia-Pacific Immuno Oncology Assays Revenue by Type (2021-2026) & (USD Million)

Table 47. Asia-Pacific Immuno Oncology Assays Revenue by Application (2016-2021) & (USD Million)

Table 48. Asia-Pacific Immuno Oncology Assays Revenue by Application (2021-2026) & (USD Million)

Table 49. Asia-Pacific Immuno Oncology Assays Revenue by Region (2016-2021) & (USD Million)

Table 50. Asia-Pacific Immuno Oncology Assays Revenue by Region (2021-2026) & (USD Million)

Table 51. South America Immuno Oncology Assays Revenue by Type (2016-2021) & (USD Million)

Table 52. South America Immuno Oncology Assays Revenue by Type (2021-2026) & (USD Million)

Table 53. South America Immuno Oncology Assays Revenue by Application (2016-2021) & (USD Million)

Table 54. South America Immuno Oncology Assays Revenue by Application (2021-2026) & (USD Million)

Table 55. South America Immuno Oncology Assays Revenue by Country (2016-2021) & (USD Million)

Table 56. South America Immuno Oncology Assays Revenue by Country (2021-2026) & (USD Million)

Table 57. Middle East & Africa Immuno Oncology Assays Revenue by Type (2016-2021) & (USD Million)

Table 58. Middle East & Africa Immuno Oncology Assays Revenue by Type (2021-2026) & (USD Million)

Table 59. Middle East & Africa Immuno Oncology Assays Revenue by Application (2016-2021) & (USD Million)

Table 60. Middle East & Africa Immuno Oncology Assays Revenue by Application (2021-2026) & (USD Million)

Table 61. Middle East & Africa Immuno Oncology Assays Revenue by Country (2016-2021) & (USD Million)

Table 62. Middle East & Africa Immuno Oncology Assays Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Immuno Oncology Assays Picture

Figure 2. Global Immuno Oncology Assays Revenue Market Share in 2020

Figure 3. Immunoassay

Figure 4. Flow Cytometry

Figure 5. PCR

Figure 6. Next Generation Sequencing

Figure 7. Immuno Oncology Assays Revenue Market Share in 2020

Figure 8. Research Picture

Figure 9. Clinical Diagnostics Picture

Figure 10. Global Immuno Oncology Assays Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Immuno Oncology Assays Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Immuno Oncology Assays Revenue Market Share by Region (2016-2026)

Figure 13. Global Immuno Oncology Assays Revenue Market Share by Region in 2020

Figure 14. North America Immuno Oncology Assays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Immuno Oncology Assays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Immuno Oncology Assays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Immuno Oncology Assays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Immuno Oncology Assays Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Immuno Oncology Assays Market Drivers

Figure 20. Immuno Oncology Assays Market Restraints

Figure 21. Immuno Oncology Assays Market Trends

Figure 22. Thermo Fischer Scientific Recent Developments and Future Plans

Figure 23. Roche Diagnostics Recent Developments and Future Plans

Figure 24. Agilent Technologies Recent Developments and Future Plans

Figure 25. Illumina Recent Developments and Future Plans

Figure 26. Global Immuno Oncology Assays Revenue Share by Players in 2020

Figure 27. Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 28. Global Top 3 Players Immuno Oncology Assays Revenue Market Share in 2020

Figure 29. Global Top 10 Players Immuno Oncology Assays Revenue Market Share in 2020

Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 31. Global Immuno Oncology Assays Revenue Share by Type in 2020

Figure 32. Global Immuno Oncology Assays Market Share Forecast by Type (2021-2026)

Figure 33. Global Immuno Oncology Assays Revenue Share by Application in 2020

Figure 34. Global Immuno Oncology Assays Market Share Forecast by Application (2021-2026)

Figure 35. North America Immuno Oncology Assays Sales Market Share by Type (2016-2026)

Figure 36. North America Immuno Oncology Assays Sales Market Share by Application (2016-2026)

Figure 37. North America Immuno Oncology Assays Revenue Market Share by Country (2016-2026)

Figure 38. United States Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 39. Canada Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 40. Mexico Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Europe Immuno Oncology Assays Sales Market Share by Type (2016-2026)

Figure 42. Europe Immuno Oncology Assays Sales Market Share by Application (2016-2026)

Figure 43. Europe Immuno Oncology Assays Revenue Market Share by Country (2016-2026)

Figure 44. Germany Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. France Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. United Kingdom Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Russia Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Italy Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Asia-Pacific Immuno Oncology Assays Sales Market Share by Type (2016-2026)

Figure 50. Asia-Pacific Immuno Oncology Assays Sales Market Share by Application (2016-2026)

Figure 51. Asia-Pacific Immuno Oncology Assays Revenue Market Share by Region (2016-2026)

Figure 52. China Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Japan Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. South Korea Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. India Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Southeast Asia Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Australia Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. South America Immuno Oncology Assays Sales Market Share by Type (2016-2026)

Figure 59. South America Immuno Oncology Assays Sales Market Share by Application (2016-2026)

Figure 60. South America Immuno Oncology Assays Revenue Market Share by Country (2016-2026)

Figure 61. Brazil Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Argentina Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Middle East and Africa Immuno Oncology Assays Sales Market Share by Type (2016-2026)

Figure 64. Middle East and Africa Immuno Oncology Assays Sales Market Share by Application (2016-2026)

Figure 65. Middle East and Africa Immuno Oncology Assays Revenue Market Share by Country (2016-2026)

Figure 66. Turkey Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Saudi Arabia Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. UAE Immuno Oncology Assays Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Methodology

Figure 70. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz